Evidence-Based Research Strategy of Traditional Chinese Medicine for Amyotrophic Lateral Sclerosis

Hao Pan,Heng Wang,Yanlin Tao,Jinfeng Yuan,Sanbin Xu,Jianli Ni,Meiqin Huang,Xiaojun Wu,Te Liu
DOI: https://doi.org/10.1155/2021/3402753
2021-09-01
Abstract:Among adult-onset motor neuron diseases, amyotrophic lateral sclerosis (ALS) is the most common. ALS involves the increasing loss of lower and upper motor neurons. Within a few years of onset, ALS causes patient death via progressive paralysis of respiratory muscles. However, the current drugs used to treat ALS, riluzole, edaravone, and dextromethorphan/quinidine, can only delay the progression of the disease and alleviate a small number of symptoms in some patients, and no completely effective treatment is available. Traditional Chinese medicine (TCM) has shown significant advantages in the treatment of ALS in China and Asia; however, the mechanism of its efficacy is unclear. This review discusses the pathogenetic hypothesis of ALS in detail from the level of neurons and glial cells and uses two current experimental animal models of ALS to design experimental strategies to study TCM treatment. We aim to provide a scientific explanation of the mechanism of the effect of TCM in the treatment of ALS, which will help clinicians and research scientists to accept the theory of TCM to treat ALS and promote the development of TCM modernization.
integrative & complementary medicine
What problem does this paper attempt to address?